Key result
OSA biomarkers and routine labs may help assess cardiovascular risk and evaluate treatment effectiveness.
Why the study?
Cause-effect relationships between cardiovascular diseases and obstructive sleep apnea syndrome remain poorly understood, requiring assessment of its independent impact on cardiovascular risk across patient subgroups.
Biomarkers and routine laboratory tests may play a role in diagnosing obstructive sleep apnea and assessing its associated cardiovascular risk.
Answers are grounded in this paper and cite their sources.
May aid CV risk assessment in OSA; leaves open prospective validation before practice change.
The review article presents a contemporary view on biomarkers of obstructive sleep apnea syndrome (OSAS) and their role in the assessment of cardiovascular risk. The cause-effect relationships between cardiovascular diseases and OSAS are still poorly understood. The assessment of an independent impact of OSAS on the cardiovascular risk in various subgroups of patients is required. It should be taken into account that one may rely not only on specific markers, but also on available routine laboratory tests in order to diagnose OSAS and evaluate the effectiveness of its treatment.
No takes yet. Share an insight, caveat, or question.
Evlampieva et al. (2020) conducted a review in Obstructive sleep apnea syndrome (OSAS) and cardiovascular risk. Biomarkers of obstructive sleep apnea syndrome was evaluated. Biomarkers and routine laboratory tests for obstructive sleep apnea syndrome may help assess cardiovascular risk and evaluate treatment effectiveness.
Synapse has enriched 10 related papers. Consider them for comparative context: